The analgesic efficacy of pregabalin for shoulder arthroscopy

Abstract

Abstract Introduction: The efficacy of pregabalin for pain management of shoulder arthroscopy remains controversial. We conduct this meta-analysis to explore the influence of pregabalin versus placebo on the postoperative pain intensity of shoulder arthroscopy. Methods: We have searched PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through November 2019 for randomized controlled trials assessing the effect of pregabalin versus placebo on pain control of shoulder arthroscopy. This meta-analysis was performed using the random-effect model. Results: Three randomized controlled trials were included in the meta-analysis. Overall, compared with control group for shoulder arthroscopy, pregabalin remarkably decreased pain scores at 0 to 1\u200ahour (Std. MD\u200a=\u200a−0.57; 95% CI\u200a=\u200a−1.04 to −0.09; P\u200a=\u200a.02) and 12\u200ahours (Std. MD\u200a=\u200a−0.37; 95% CI\u200a=\u200a−0.72 to −0.02; P\u200a=\u200a.04), as well as analgesic consumption (Std. MD\u200a=\u200a−1.84; 95% CI\u200a=\u200a−2.24 to −1.44; P\u200a<\u200a.00001), but showed no notable influence on pain scores at 24\u200ahours (Std. MD\u200a=\u200a−0.54; 95% CI\u200a=\u200a−1.47 to 0.38; P\u200a=\u200a.25), nausea or vomiting (RR\u200a=\u200a0.84; 95% CI\u200a=\u200a0.53–1.33; P\u200a=\u200a.45), dizziness (RR\u200a=\u200a1.14; 95% CI\u200a=\u200a0.89–1.47; P\u200a=\u200a.30). Conclusions: Pregabalin may benefit to pain control after shoulder arthroscopy.